USA: In the ACHIEVE-3 trial published in The Lancet, once-daily orforglipron demonstrated greater reductions in HbA1c and body weight compared with once-daily oral semaglutide in adults with type 2 diabetes.…
Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis,…
New Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and weight-loss molecule, leading to…
China: A new study published in BMC Surgery suggests that intramedullary nailing may offer faster recovery and improved functional outcomes compared with dual-plate fixation in selected patients with proximal humeral…
A first-in-human, phase I single-arm trial has found that in-utero treatment of myelomeningocele, the most severe form of spina bifida, using allogeneic live stem cells was both feasible and safe.…
New Delhi: Emcure Pharmaceuticals has announced the signing of a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio, marking a significant step toward expanding…
New Delhi: The Appointments Committee of the Cabinet has cleared yet another extension for Dr Rajeev Singh Raghuvanshi as Drugs Controller (India) at the Central Drugs Standard Control Organisation (CDSCO),…
New Delhi: Cipla Limited has announced that it has entered into a 60:40 joint venture agreement with Kemwell Biopharma Private Limited for incorporation of a new joint venture company in…
A new study published in The New England Journal of Medicine revealed that the antiviral drug tecovirimat did not significantly improve recovery outcomes among adults infected with the clade II…
A new study published in the Journal of the American Medical Association showed that there was a dose-response relationship between the number of pre-existing maternal chronic illnesses and the likelihood…